Atlantic Health Strategies

Recovery Works Exits Kentucky: What the Pinnacle Closure Signals for Behavioral Health M&A

Table of Contents

Ready to See Results?

From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.

The answer: a PE-backed portfolio just told the market what impaired residential looks like

Pinnacle Treatment Centers’ wind-down of Recovery Works’ Kentucky inpatient detox and residential operations, including the shuttered Georgetown facility, is a live case study in how payer mix erosion, census volatility, and state reimbursement sufficiency can force PE-backed operators to shed underperforming residential assets. For acquirers and portfolio holders, it reframes diligence around utilization sustainability, Kentucky Medicaid rate adequacy, and post-close integration risk.

Behavioral Health Business reported that Recovery Works stopped accepting new patients and will cease inpatient detox and residential services across all existing Kentucky locations. The Georgetown facility, a 27,600-square-foot site on 10 acres, operated between 31 and 50 inpatient beds and treated adults with co-occurring mental health and substance use disorders. The property had been listed for sale for at least 153 days before local reporting caught up. Read that timeline again. Five months on the market is not a strategic pivot. That is a distressed asset.

Pinnacle is a Linden Capital Partners portfolio company. The parent operates more than 130 locations across nine states including Georgia, Indiana, Kentucky, New Jersey, North Carolina, Ohio, Pennsylvania, and Virginia, and in December 2025 named its third CEO in the last two years. Three CEOs in 24 months and a state-level residential wind-down in the same window is not a coincidence. It is a portfolio rationalization signal.

What the Kentucky exit actually tells buyers about diligence

Recovery Works Exits Kentucky: What the Pinnacle Closure Signals for Behavioral Health M&A — What the Kentucky exit actually tells buyers about diligence

Kentucky is not New Jersey or Pennsylvania. It is a Medicaid-heavy, non-CON state where residential SUD economics hinge on the Department for Medicaid Services (DMS) per diem, the 1115 SUD waiver’s IMD exclusion carve-out, and the Cabinet for Health and Family Services (CHFS) Office of Inspector General licensure regime. If your pro forma assumed commercial mix would carry a residential asset in a secondary Kentucky market, you were wrong before you closed.

The Recovery Works Georgetown site carried a real clinical footprint. CARF records show programs including Detoxification/Withdrawal Management-Residential, ASAM Level 3.5, Residential Treatment, and ASAM Level 3.7. That is a serious level-of-care stack. Under the ASAM Criteria 4th Edition, Level 3.7 is Residential Detoxification (residential withdrawal management), which is the highest-acuity, highest-cost, highest-staffing bed in the building. Kentucky Medicaid pays roughly $350 to $450 per diem for residential SUD depending on level, and when a Medicaid-dominant payer mix meets 3.7 staffing ratios and census dips below 75%, the math breaks fast.

For acquirers screening residential SUD platforms right now, I would name five diligence red flags this closure surfaces:

  • State-specific Medicaid per diem versus fully-loaded cost per bed day at Level 3.7 and Level 3.5. If the per diem does not cover nursing plus prescriber plus 24/7 monitored withdrawal management, the operator is subsidizing every Medicaid admission.
  • Payer mix concentration. A residential asset with more than 70% Medicaid revenue in a secondary market is a rate action away from impairment.
  • Census trend over 24 months, not 6. Ask sellers for weekly average daily census by level of care. Volatility inside a single quarter is the tell.
  • Time on market for underperforming real estate inside the platform. If sister sites are already listed under separate brokers, the deck sellers showed is stale.
  • Licensure and DEA registration standing at every location. Kentucky OIG licensure is site-specific. DEA registrations do not transfer on close without action.

The M&A market context: a slower, more forensic buyer

The Pinnacle move lands in a market that has already recalibrated. In the first quarter of 2026, there were only five SUD deals, down from seven in Q4 2025 and eight in Q1 2025, according to Mertz Taggart. Both Mertz Taggart and The Braff Group show a steep drop-off from the peak of dealmaking in 2021: down 54% and 52% respectively. Buyer interest in out-of-network offerings and residential or inpatient care settings has cooled as investment destinations.

Lenders are also different animals now. Mertz Taggart’s Q4 2025 report describes deal timelines lengthening as lenders conducted “forensic” diligence on insurance receivables and cash collections, and a “flight to quality” theme, where premium assets with strong outcomes still command high multiples while distressed situations are increasingly common. As Kevin Taggart told BHB about the SUD market: “BayMark used to be one of the most acquisitive buyers in the SUD space, but hasn’t bought anything in three-plus years,” and that reset matters for anyone modeling exit multiples.

What that means practically: if a portfolio holder is sitting on a Kentucky, Indiana, or Ohio residential site with a shaky payer mix, the buyer who would have paid 8x adjusted EBITDA in 2021 wants 24-month census trend data, denial rate by payer, utilization management appeal win rate, and the last three CHFS and Joint Commission survey reports before signing an NDA. Deals that used to close in 90 days now stretch past 180.

Operator-side lessons: exit-readiness is not a slide, it is a habit

Every operator I speak with says they want to be exit-ready. Very few actually operate that way. The Recovery Works Kentucky wind-down is a reminder that the difference between a divestiture and a shutdown is often 18 months of unglamorous operational work that owners should have started long before the sale process.

Here is what exit-ready looks like on the ground, not on a pitch deck:

  • Clean licensure files at the state OIG or equivalent, with no open findings. Kentucky CHFS surveyors will not care that a facility is mid-transaction.
  • DEA registrations current at every site, with a documented transfer plan. On closure, the DEA requires surrender or transfer of controlled substance inventory and registration wind-down. On acquisition, the buyer must obtain new registration at each location before dispensing.
  • Joint Commission or CARF accreditation on the three-year cycle, not the probationary cycle. Recently our team earned Joint Commission Accreditation across five facilities in three states, three levels of care, all accredited for three years. That is what a buyer wants to see in the data room.
  • Managed care contracts loaded in a single register with effective date, timely filing window, rate schedule, and utilization management protocol per payer.
  • Monthly SIU audit readiness reviews. If a payer Special Investigations Unit opens on the target the week after close, the buyer inherits the exposure.
  • A real census dashboard by level of care, updated weekly, with occupancy targets tied to breakeven. If clinical leadership cannot state the Level 3.5 breakeven census on demand, the operator is not exit-ready.

The uncomfortable truth about Kentucky (and Indiana, and North Carolina, and every non-CON secondary market where residential SUD lives): the state does not owe operators a sustainable per diem. SAMHSA does not owe operators a census. The 1115 waiver does not owe operators an IMD carve-out that survives every state plan amendment. Owners either build the operational backbone that lets them survive rate compression, or they become someone else’s case study.

Recovery Works Exits Kentucky: What the Pinnacle Closure Signals for Behavioral Health M&A — Operator-side lessons: exit-readiness is not a slide, it is a habit

Frequently asked questions

What diligence red flags should acquirers screen for after the Recovery Works Kentucky exit?
Payer mix concentration above 70% Medicaid in a secondary market, per diem rates that do not cover fully-loaded Level 3.7 or Level 3.5 staffing (often $500 to $650 per bed day fully loaded), 24-month census volatility, real estate inside the target platform already listed under separate brokers, and any open state licensure or DEA findings at the site level. Buyers should ask for weekly average daily census by level of care, not a rolled-up annual figure.

How do state Medicaid per diem rates affect residential SUD viability in secondary markets?
Kentucky DMS sets residential SUD per diems that must cover nursing, prescriber coverage, ancillary services, room and board where applicable, and the fixed cost of 24/7 monitored withdrawal management at Level 3.7. In secondary markets with limited commercial payer volume, the Medicaid per diem is not a floor, it is the ceiling. If DMS does not raise rates in line with wage inflation (Kentucky RN wages rose more than 20% between 2020 and 2024), the facility’s breakeven census keeps climbing until the math stops working. The 1115 SUD waiver’s IMD carve-out determines whether facilities over 16 beds can bill Medicaid at all for adults, which is existential for a 31-to-50 bed site.

What licensure and DEA steps are required when a PE-backed operator closes a residential facility?
The operator must notify the state licensing authority (in Kentucky, CHFS Office of Inspector General) of the closure, submit a patient transition plan, and coordinate with SAMHSA if the site is an OTP under 42 CFR Part 8. Controlled substance inventory must be surrendered, transferred, or reverse-distributed per DEA rules, and the DEA registration wound down. 42 CFR Part 2 records require secure retention or destruction under strict confidentiality protocols. Owners who skip any of these steps create residual liability that survives the closure.

How should portfolio operators decide between divesting versus repositioning an underperforming residential asset?
Run the math both ways with real numbers. If the site can hit breakeven census (typically 80% occupancy) at the current Medicaid per diem plus a realistic commercial mix within 12 months and the state’s licensure and accreditation status is clean, reposition. If the payer mix cannot be shifted, the per diem is structurally below cost, and the CEO turnover suggests operational drift, divest early while there are still buyers who will pay for the real estate and the licensure. Waiting until the site has been listed 153 days destroys value.

What census and payer-mix thresholds indicate a residential SUD facility is exit-ready versus impaired?
Exit-ready generally means 85%+ average daily census over the trailing 12 months, commercial and Medicare Advantage at 30% or more of revenue, denial rates under 8% by payer, timely filing compliance above 98%, and no open state or accreditor findings. Impaired looks like sub-70% census, Medicaid concentration above 80% in a non-carve-out state, denial rates above 15%, and a 12-month EBITDA margin below zero after real management fees are added back. Between those two states is where operators need advisory help fast, not later.

Request a Free Consultation

Scroll to Top